Navigate to
472 Results for GLP-1 Pipeline Update
-
Live updates from AMCP Annual Meeting
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
ensitrelvir - Infectious disease Name Manufacturer Clinical use Dosage form Development status - FDA designations FDA decision oxylanthanum carbonate (Renazorb) Unicycive Hyperphosphatemia (in...
-
-
Table view Editor-in-chief's message Year 2024 2025 2026 2027 2028 Projected Yearly U.S. Sales $0 $82 $177 $258 $311 The pipeline drug list is an aerial outline of drugs with anticipated FDA...